{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:45:06Z","timestamp":1690245906308},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,7]],"date-time":"2012-04-07T00:00:00Z","timestamp":1333756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12328-012-0294-5","type":"journal-article","created":{"date-parts":[[2012,4,6]],"date-time":"2012-04-06T16:24:51Z","timestamp":1333729491000},"page":"183-188","source":"Crossref","is-referenced-by-count":5,"title":["Overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis complicated with hepatocellular carcinoma"],"prefix":"10.1007","volume":"5","author":[{"given":"Kazuto","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Kogita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Tsuchimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Sawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Igura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Ohama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichirou","family":"Zushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,7]]},"reference":[{"key":"294_CR1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","volume":"139","author":"AL Czala","year":"2010","unstructured":"Czala AL, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139:58\u201372.","journal-title":"Gastroenterology"},{"key":"294_CR2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660\u201378.","journal-title":"Hepatology"},{"key":"294_CR3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","volume":"33","author":"M Kaya","year":"2000","unstructured":"Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol. 2000;33:537\u201342.","journal-title":"J Hepatol"},{"key":"294_CR4","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","volume":"100","author":"A Floreani","year":"2005","unstructured":"Floreani A, Rizzotto ER, Ferrara F, Carderi I, Caroli D, Blasone L, et al. Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol. 2005;100:1516\u201322.","journal-title":"Am J Gastroenterol"},{"key":"294_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","volume":"43","author":"S L\u00fcth","year":"2009","unstructured":"L\u00fcth S, Kanzler S, Frenzel C, Kasper HU, Dienes HP, Schramm C, et al. Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. J Clin Gastroenterol. 2009;43:75\u201380.","journal-title":"J Clin Gastroenterol"},{"key":"294_CR6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"3","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M. AASLD practice guideline. Management of hepatocellular carcinoma: an update. Hepatology. 2011;3:1020\u20132.","journal-title":"Hepatology"},{"key":"294_CR7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","volume":"48","author":"AD Yeoman","year":"2008","unstructured":"Yeoman AD, Al-Chalabi T, Karani JB, Quaglia A, Devlin J, Mieli-Vergani G, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology. 2008;48:863\u201370.","journal-title":"Hepatology"},{"key":"294_CR8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10620-010-1444-6","volume":"56","author":"RJ Wong","year":"2011","unstructured":"Wong RJ, Gish R, Frederick T, Bzoweji N, Frenette C. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series. Dig Dis Sci. 2011;56:578\u201385.","journal-title":"Dig Dis Sci"},{"key":"294_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u201376.","journal-title":"Hepatology"},{"key":"294_CR10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","volume":"33","author":"GV Gregorio","year":"2001","unstructured":"Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, et al. Autoimmune hepatitis\/sclerosing overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001;33:544\u201353.","journal-title":"Hepatology"},{"key":"294_CR11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","volume":"47","author":"R Abdalian","year":"2008","unstructured":"Abdalian R, Dhar P, Jhaveri K, Haider M, Guindi M, Heathcote EJ. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology. 2008;47:949\u201357.","journal-title":"Hepatology"},{"key":"294_CR12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","volume":"50","author":"M Lewin","year":"2009","unstructured":"Lewin M, Vilgrain V, Ozenne V, Lemoine M, Wendum D, Paradis V, et al. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study. Hepatology. 2009;50:528\u201337.","journal-title":"Hepatology"},{"key":"294_CR13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/jhep.2002.37200","volume":"36","author":"AA Abdo","year":"2002","unstructured":"Abdo AA, Bain VG, Kichian K, Lee SS. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome. Hepatology. 2002;36:1393\u20139.","journal-title":"Hepatology"},{"key":"294_CR14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0168-8278(00)80005-7","volume":"33","author":"HR Buuren","year":"2000","unstructured":"Buuren HR, Hoogstraten HJF, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol. 2000;33:543\u20138.","journal-title":"J Hepatol"},{"key":"294_CR15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/BF01213311","volume":"32","author":"H Takikawa","year":"1997","unstructured":"Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan-analysis of 192 cases. J Gastroenterol. 1997;32:919\u201335.","journal-title":"J Gastroenterol"},{"key":"294_CR16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2169\/internalmedicine.41.696","volume":"41","author":"J Takiguchi","year":"2002","unstructured":"Takiguchi J, Ohira H, Rai T, Shishido S, Tojo J, Sato Y, et al. Autoimmune hepatitis overlapping with primary sclerosing cholangitis. Intern Med. 2002;41:696\u2013700.","journal-title":"Intern Med"},{"key":"294_CR17","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1572-0241.2008.01922.x","volume":"103","author":"AJ Montano-Loza","year":"2008","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis. Am J Gastroenterol. 2008;103:1944\u201351.","journal-title":"Am J Gastroenterol"},{"key":"294_CR18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","volume":"99","author":"K Burak","year":"2004","unstructured":"Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:523\u20136.","journal-title":"Am J Gastroenterol"},{"key":"294_CR19","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/hep.21433","volume":"44","author":"H Prytz","year":"2006","unstructured":"Prytz H, Keiding S, Bjornsson E. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology. 2006;44:1572\u201380.","journal-title":"Hepatology"},{"key":"294_CR20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","volume":"27","author":"DM Harnois","year":"1997","unstructured":"Harnois DM, Gores JG, Ludwig J, Steers JL, LaRusso NE, Wiesner RH. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol. 1997;27:512\u20136.","journal-title":"J Hepatol"},{"key":"294_CR21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0168-8278(01)00042-3","volume":"34","author":"M Leidenius","year":"2001","unstructured":"Leidenius M, Hockersted K, Broome U, Ericzon BG, Friman S, Olauson M, et al. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. J Hepatol. 2001;34:792\u20138.","journal-title":"J Hepatol"},{"key":"294_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12328-010-0137-1","volume":"3","author":"C Maeda","year":"2010","unstructured":"Maeda C, Tamano M, Murohisa T, Yamagishi T, Hashimoto T, Kojima K, et al. Hepatocellular carcinoma associated with noncirrhotic autoimmune hepatitis. Clin J Gastroenterol. 2010;3:111\u20135.","journal-title":"Clin J Gastroenterol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-012-0294-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-012-0294-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-012-0294-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:57:25Z","timestamp":1559447845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-012-0294-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1007\/s12328-012-0294-5","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,7]]}}}